| Followers | 1129 |
| Posts | 32786 |
| Boards Moderated | 3 |
| Alias Born | 01/11/2016 |
Tuesday, June 03, 2025 7:24:00 PM
"Yes, Moelis & Company has been involved in advisory roles for companies traded on the over-the-counter (OTC) markets. Notably, in February 2021, Moelis & Company was engaged as a financial advisor by MedMen Enterprises Inc. (OTCQX: MMNFF), a cannabis retailer, to assist in analyzing various strategic alternatives to position the company for future success and maximize stakeholder value .
reddit.com
Additionally, Moelis & Company has advised on mergers and acquisitions involving companies listed on major exchanges, such as the $61.2 billion sale of Anheuser-Busch to InBev and the $35 billion merger of Omnicom Group and Publicis Groupe .
forbes.com
+2
en.wikipedia.org
+2
valuewalk.com
+2
While MedMen Enterprises Inc. is traded on the OTCQX, a premium tier of the OTC Markets Group, it is not listed on a major exchange. This indicates that Moelis & Company has experience advising companies in the OTC market, though such engagements may be less frequent compared to those involving companies listed on major exchanges.
For more information on Moelis & Company's transactions, you can visit their official transactions archive"
reddit.com
Additionally, Moelis & Company has advised on mergers and acquisitions involving companies listed on major exchanges, such as the $61.2 billion sale of Anheuser-Busch to InBev and the $35 billion merger of Omnicom Group and Publicis Groupe .
forbes.com
+2
en.wikipedia.org
+2
valuewalk.com
+2
While MedMen Enterprises Inc. is traded on the OTCQX, a premium tier of the OTC Markets Group, it is not listed on a major exchange. This indicates that Moelis & Company has experience advising companies in the OTC market, though such engagements may be less frequent compared to those involving companies listed on major exchanges.
For more information on Moelis & Company's transactions, you can visit their official transactions archive"
Recent TGLO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 09:51:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 07:30:16 PM
